STAT3 and gastric cancer: Effective blockade of the STAT3 activity by STAT3 inhibitor sensitized gastric cancer cells to cisplatin and reduced the cisplatin‐resistant‐related gene G3BP2, THOC1, ATP7A, and OTUD1 expression [41, 42, 43, 44, 45].